RF|Binder Partners unit is supporting Ranbaxy Pharmaceuticals as the drug marketer rolls out the first generic competition to Pfizer’s blockbuster cholesterol drug Lipitor.

Read the full story (sub req'd) | Subscribe to O'Dwyer's